Novo Nordisk Halts Type 1 Diabetes Cure Research

Novo Nordisk just dropped a bombshell: they're axing their entire cell therapy division, effectively halting research into a potential cure for type one diabetes. What does this mean for the future of diabetes treatment and the hopes of patients worldwide? Find out how this decision is sending shockwaves through the research community and who might step up to fill the void. Hosted on Acast. See acast.com/privacy for more information.